Andra AP-fonden’s ResMed RMD Stock Holding History

Andra AP-fonden’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.9M	Buy	84,343 +68,661	+438%	+$17.1M	0.23%	104
2025 Q4	$3.78M	Buy	15,682 +11,001	+235%	+$2.81M	0.05%	303
2025 Q3	$1.28M	Sell	4,681 -90,519	-95%	-$24.7M	0.02%	366
2025 Q2	$24.6M	Buy	95,200 +11,289	+13%	+$2.69M	0.34%	107
2025 Q1	$18.8M	Buy	83,911 +45,211	+117%	+$10.6M	0.31%	119
2024 Q4	$8.85M	Buy	+38,700	New	+$9.32M	0.14%	225
2023 Q3	–	Sell	-25,500	Closed	-$5.57M	–	504
2023 Q2	$5.57M	Sell	25,500 -5,800	-19%	-$1.29M	0.14%	343
2023 Q1	$6.85M	Sell	31,300 -9,700	-24%	-$2.1M	0.18%	252
2022 Q4	$8.53M	Buy	41,000 +5,300	+15%	+$1.16M	0.26%	112
2022 Q3	$7.79M	Sell	35,700 -7,700	-18%	-$1.75M	0.26%	124
2022 Q2	$9.1M	Buy	+43,400	New	+$9.24M	0.26%	103
2021 Q4	$15.5M	Sell	59,500 -14,900	-20%	-$3.87M	0.32%	59
2021 Q3	$19.6M	Sell	74,400 -900	-1%	-$246K	0.4%	8
2021 Q2	$18.6M	Buy	75,300 +11,400	+18%	+$2.4M	0.38%	9
2021 Q1	$12.4M	Sell	63,900 -100	-0.2%	-$20.1K	0.27%	72
2020 Q4	$13.6M	Buy	64,000 +15,500	+32%	+$3.09M	0.3%	37
2020 Q3	$8.31M	Buy	48,500 +200	+0.4%	+$36.9K	0.23%	117
2020 Q2	$9.27M	Buy	48,300 +2,800	+6%	+$458K	0.27%	36
2020 Q1	$6.7M	Buy	45,500 +11,100	+32%	+$1.77M	0.24%	42
2019 Q4	$5.33M	Sell	34,400 -7,100	-17%	-$1.02M	0.15%	334
2019 Q3	$5.61M	Buy	41,500 +1,700	+4%	+$223K	0.17%	283
2019 Q2	$4.86M	Sell	39,800 -19,200	-33%	-$2.13M	0.14%	383
2019 Q1	$6.13M	Buy	+59,000	New	+$6.09M	0.18%	232
2018 Q3	$8.02M	Buy	69,500 +24,500	+54%	+$2.68M	0.21%	159
2018 Q2	$4.66M	Sell	45,000 -17,700	-28%	-$1.79M	0.13%	410
2018 Q1	$6.17M	Buy	62,700 +23,700	+61%	+$2.24M	0.16%	292
2017 Q4	$3.3M	Sell	39,000 -2,200	-5%	-$182K	0.08%	410
2017 Q3	$3.17M	Buy	41,200 +13,100	+47%	+$1M	0.07%	423
2017 Q2	$2.19M	Buy	28,100 +2,900	+12%	+$207K	0.05%	509
2017 Q1	$1.81K	Buy	25,200 +2,300	+10%	+$159K	0.04%	512
2016 Q4	$1.42M	Sell	22,900 -31,500	-58%	-$1.93M	0.04%	539
2016 Q3	$3.52M	Sell	54,400 -4,900	-8%	-$326K	0.09%	343
2016 Q2	$3.75M	Buy	59,300 +36,000	+155%	+$2.12M	0.1%	320
2016 Q1	$1.35M	Sell	23,300 -2,300	-9%	-$130K	0.04%	587
2015 Q4	$1.37M	Sell	25,600 -3,500	-12%	-$197K	0.04%	528
2015 Q3	$1.48M	Buy	29,100 +4,000	+16%	+$215K	0.04%	528
2015 Q2	$1.42M	Buy	25,100 +16,800	+202%	+$1.06M	0.04%	528
2015 Q1	$596K	Buy	+8,300	New	+$539K	0.02%	588
2014 Q2	–	Sell	-10,400	Closed	-$465K	–	573
2014 Q1	$465K	Sell	10,400 -87,400	-89%	-$3.93M	0.01%	532
2013 Q4	$4.6M	Sell	97,800 -8,300	-8%	-$420K	0.11%	299
2013 Q3	$5.6M	Hold	106,100	–	–	0.14%	249
2013 Q2	$4.79M	Buy	+106,100	New	+$5.03M	0.12%	281

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Andra AP-fonden's RMD Position: Q1 2026 in Review

Andra AP-fonden increased its ResMed (RMD) stake by 438% in Q1 2026, buying an estimated $17.1M and bringing the position to 84,343 shares worth $18.9M. The position accounts for 0.23% of the portfolio, ranked #104.

Andra AP-fonden first reported a position in RMD in Q2 2013 and has held it in 42 quarters since. The position peaked at $24.6M in Q2 2025. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Andra AP-fonden held 84,343 shares of ResMed worth $18.9M as of Q1 2026.
Andra AP-fonden bought 68,661 ResMed shares in Q1 2026, an estimated $17.1M.
ResMed made up 0.23% of Andra AP-fonden's portfolio in Q1 2026, its #104 holding.
Andra AP-fonden first reported a position in ResMed in Q2 2013 and has held it in 42 quarters since.
Andra AP-fonden's ResMed position peaked at $24.6M in Q2 2025.
940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.